deltatrials
Completed OBSERVATIONAL NCT03983707

A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding (POPS)

A Multicentre Prospective Observational Study to Evaluate the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding

Sponsor: 3-D Matrix Europe SAS

Interventions Purastat®
Updated 7 times since 2019 Last updated: May 27, 2025 Started: Jan 23, 2019 Primary completion: Oct 31, 2021 Completion: Oct 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Delayed Bleeding and Gastrointestinal Bleeding, this trial is completed. The trial is conducted by 3-D Matrix Europe SAS and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Nov 2022 · 13 months · monthly snapshotUnknown Status~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotCompleted~Jun 2025 – present · 13 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Jun 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Jun 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Nov 2022 — Jul 2024 [monthly]

    Completed

    Status: Unknown StatusCompleted

  5. Oct 2021 — Nov 2022 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

Show 2 earlier versions
  1. Jan 2021 — Oct 2021 [monthly]

    Recruiting

  2. Jul 2019 — Jan 2021 [monthly]

    Recruiting

    First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • 3-D Matrix Europe SAS
  • Barts & The London NHS Trust
  • Brighton and Sussex University Hospitals NHS Trust
  • Cambridge University Hospitals NHS Foundation Trust
  • East Kent Hospitals University NHS Foundation Trust
  • Glasgow Royal Infirmary
  • Gloucestershire Hospitals NHS Foundation Trust
  • Guy's and St Thomas' NHS Foundation Trust
  • Heart of England NHS Foundation Trust
  • Imperial College Healthcare NHS Trust
  • King's College Hospital NHS Trust
  • London North West Healthcare NHS Trust
  • Manchester University NHS Foundation Trust
  • Mid and South Essex NHS Foundation Trust
  • North Tees and Hartlepool NHS Foundation Trust
  • Northern Care Alliance NHS Foundation Trust
  • Nottingham University Hospitals NHS Trust
  • Oxford University Hospitals NHS Trust
  • Portsmouth Hospitals NHS Trust
  • The Leeds Teaching Hospitals NHS Trust
  • University College London Hospitals
  • University Hospital Birmingham NHS Foundation Trust
  • University Hospital Southampton NHS Foundation Trust
Data source: Portsmouth Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations